Dergiler / Medicine Science / 2020 / Cilt: 9 - Sayı: 4

A common but not well-known cause in anal fissure development and treatment failure: Isotretinoin treatment for acne vulgaris

Sayfa
970–977
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

SIT, a very successful treatment for nodulocystic acne disease, can facilitate AF development in younger individuals with a low BMI even without significant constipation.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:To investigate the underrecognized effects of isotretinoin as a cause of anal fissures (AF) and compare AF patients undergoing systemic isotretinoin treatment (SIT) and those not receiving this treatment.
📊
Temel Bulgular & Veri:This study was conducted with 118 patients with newly diagnosed AF, 54 undergoing SIT (Group 1) and 64 not undergoing SIT (Group 2).
💡
Sonuç & Katkı:SIT, a very successful treatment for nodulocystic acne disease, can facilitate AF development in younger individuals with a low BMI even without significant constipation.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

To investigate the underrecognized effects of isotretinoin as a cause of anal fissures (AF) and compare AF patients undergoing systemic isotretinoin treatment (SIT) and those not receiving this treatment. This study was conducted with 118 patients with newly diagnosed AF, 54 undergoing SIT (Group 1) and 64 not undergoing SIT (Group 2). The same clinical treatment modalities including first-line conservative and medical treatments during the first eight weeks, followed by interventional methods (botulinum injection or sphincterotomy) for unresponsive/recurrent cases were used for all patients. A comparative analysis was also performed. Age and body mass index (BMI) were statistically low in group 1 (p=0.003; p=0.032). Similarly, the VAS pain and Wexner constipation scores and the duration of symptoms were lower in group 1 than Group 2 (p=0.003, p<0.001, and p<0.001, respectively). Atypical fissure localization was clearly associated with group 1 (p=0.012), and although SIT did not increase the surgery rate, atypical fissures and longer symptom duration constituted the most important factors determining requirement of surgical. SIT, a very successful treatment for nodulocystic acne disease, can facilitate AF development in younger individuals with a low BMI even without significant constipation.

🔖

Bu Makaleye Atıf Yap

BASIM, P., YÜKSEL, M. (2020). A common but not well-known cause in anal fissure development and treatment failure: Isotretinoin treatment for acne vulgaris. Medicine Science, Cilt: 9 - Sayı: 4, 970–977. https://ajindex.com/articles/276778

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (18)

  1. Brady JT, Althans AR, Neupane R, et al. Treatment for anal fissure: Is there a safe option? Am J Surg. 2017;214:623-8
  2. Beaty JS, Shashidharan M. Anal fissure. Clin Colon Rectal Surg. 2016;29:30-7
  3. Steinhagen E. Anal fissure. Dis Colon Rectum. 2018;61:293-7
  4. Lund JN, Scholefield JH. Aetiology and treatment of anal fissure. Br J Surg. 1996;83:1335-44
  5. Gibbons CP, Read NW. Anal hypertonia in fissures: cause or effect? Br J Surg. 1986;73:443-5
  6. Keck JO, Stauniunas RJ, Coller JA, et al. Computer-generated profiles of the anal canal in patients with anal fissure. Dis Colon Rectum. 1995;38:72- 9
  7. Stewart DB Sr, Gaertner W, Glasgow S, et al. Clinical practice guideline for the management of anal fissures. Dis Colon Rectum. 2017;60:7-14
  8. Cross KL, Massey EJ, Fowler AL, et al. The management of anal fissure: ACPGBI position statement. Colorectal Dis. 2008;10:1-7
  9. Altomare DF, Binda GA, Canuti S, et al. The management of patients with primary chronic anal fissure: a position paper. Tech Coloproctol. 2011;15:135-41
  10. Nelson R. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2003
  11. Wald A, Bharucha AE, Cosman BC, et al. ACG clinical guideline: management of benign anorectal disorders. Am J Gastroenterol. 2014;109:1141-57
  12. Emile SH, Elgendy H, Elfeki H, et al. Does the duration of symptoms of anal fissure impact its response to conservative treatment? A prospective cohort study. Int J Surg. 2017;44:64-70
  13. Karadağ ŞG, Sönmez HE, Tanatar A, et al. Isotretinoin-induced sacroiliitis: Case series of four patients and a systematic review of the literature. Pediatr Dermatol. 2019;37:171-5
  14. Güngör S, Gökdemir G. Anal fissure and rectal bleeding as a complication of systemic isotretinoin therapy: dermatologists know this side-effect, what about proctologists? Colorectal Dis. 2013;15:1187-8
  15. Erpolat S, Gorpelioglu C, Sarifakioglu E. Isotretinoin associated anal fissure and rectal bleeding: a rare complication. Int J Dermatol. 2012;51:358-9
  16. Radmanesh M. Anal fissure, rectal bleeding and proctitis as complications of systemic isotretinoin therapy: report of two cases. J Eur Acad Dermatol Venereol. 2006;20:1394
  17. Sinha R, Kaiser AM. Efficacy of management algorithm for reducing need for sphincterotomy in chronic anal fissures. Colorectal Dis. 2012;14:760-4
  18. Acar T, Acar N, Gungor F, et al. Treatment of chronic anal fissure: Is open lateral internal sphincterotomy (LIS) a safe and adequate option? Asian J